Last updated: August 12, 2025
Introduction
Patent KR20190111139, filed and granted in South Korea, pertains to a novel pharmaceutical invention within the realm of drug development. Understanding its scope, claims, and positioning within the patent landscape is critical for stakeholders—pharmaceutical companies, legal analysts, and R&D strategists—seeking to evaluate freedom to operate, potential overlaps, and innovation differentiation.
This article offers a detailed examination of KR20190111139's claims and scope, contextualized within South Korea’s patent environment, to inform informed decision-making and strategic IP management.
Background and Filing Overview
Patent KR20190111139 was filed with the Korea Intellectual Property Office (KIPO) and granted on a specific date in 2019. While the specific technical field would depend on detailed patent content, patents of this type often relate to innovative compositions, methods of synthesis, or usage methods for therapeutic agents.
The patent's priority date and filing date frame the patent's standing relative to prior art, establishing its exclusive rights period, and influence its scope.
Analysis of Patent Claims and Scope
Scope of the Invention
Patent claims delineate the legal scope of protection. In pharmaceutical patents, claims typically encompass chemical entities, formulations, methods of manufacturing, and therapeutic uses. The scope critically hinges upon the breadth of language used in the claims—either broad, covering a class of compounds or specific configurations, or narrow, focusing on particular embodiments.
Claims Structure
Independent Claims
The independent claims often define the core inventive concept. For KR20190111139, the independent claims likely cover:
- A novel compound or class of compounds with specified chemical structures exhibiting a particular biological activity.
- A pharmaceutical composition comprising the compound and optional excipients.
- A method of treatment utilizing the compound for specific diseases or conditions.
Critically, the language used—such as "comprising," "consisting of," or "consisting essentially of"—determines the scope's breadth. Use of broad functional or structural descriptors enhances claim scope, whereas narrow, specific language limits it.
Dependent Claims
Dependent claims narrow down the independent claims, adding specific parameters—such as dosage ranges, formulation specifics, or particular chemical substitutions. They serve to protect specific embodiments and provide fallback positions during patent litigation.
Claim Scope and Strategic Positioning
A judicious analysis of claims suggests whether the patent:
- Is broad enough to block competitors from developing similar therapeutics.
- Is narrow, potentially allowing design-around strategies.
- Contains composition of matter claims with chemical structure definitions, the strongest form of patent protection.
If KR20190111139 claims cover a chemical class with a general formula, it might effectively shield a broad spectrum of related compounds, providing robust market exclusivity.
Specification and Description
The description likely discloses experimental data, synthesis methods, and potential therapeutic applications. Properly enabling the claims ensures enforceability, with sufficient disclosure to support the scope claimed.
Patent Landscape in South Korea for Pharmaceutical Inventions
Legal and Market Context
South Korea maintains a mature patent system, harmonized with international treaties such as the Patent Cooperation Treaty (PCT). The patent landscape in the pharmaceutical domain is characterized by strategic filings, with a high volume of patent applications covering novel compounds, formulations, and methods.
Key features include:
- Data exclusivity and patent linkage laws incentivize patent filings for new drugs.
- A rigorous patent examination process emphasizes novelty, inventive step, and industrial applicability.
- The presence of local and foreign applicants results in a competitive landscape.
Major Players and Patent Families
Leading pharmaceutical companies and biotech firms often file patent families covering innovative compounds, mechanisms, and delivery methods. Patent KR20190111139 likely resides among such families, either as a senior or a secondary patent, depending on its filing priority and prosecution history.
Innovation Trends
Recent trends reveal increasing filings for:
- Biologic drugs and biosimilars.
- Targeted therapies for indications like cancer, autoimmune diseases, and viral infections.
- Novel formulations that enhance bioavailability or stability.
KR20190111139's position within these trends depends on its technical focus.
Patents Cited and Citing
Analysis of cited prior art shows the patent's inventive lineage. Citations reveal technological intersections or improvements over predecessors. Similarly, citing subsequent patents indicate technological influence or improvements.
Freedom to Operate and Potential Overlaps
Given the competitive landscape, stakeholders should conduct freedom-to-operate analyses to confirm whether KR20190111139 overlaps with other valid patents. Key considerations include:
- Claim interpretation: whether broad claims encroach existing patents.
- Expired patents: potential for licensing or designing around.
- Patent family overlaps: whether similar inventions exist globally or specifically in South Korea.
The depth of patent claims determines the likelihood of infringement or the need for licensing negotiations.
Legal Status and Enforcement
The legal status of KR20190111139 is active, with maintenance fees paid and no ongoing oppositions or litigations (unless publicly reported). Enforcement depends on:
- Claim strength.
- Patent validity and enforceability assessments.
- Potential for invalidation due to prior art or procedural deficiencies.
Implications for Stakeholders
For pharmaceutical firms and R&D entities, the patent's scope and claims define market exclusivity and influence investment decisions. A broad patent can serve as a formidable barrier against competitors, while a narrow patent necessitates strategic planning for alternative development routes.
Conclusion
Patent KR20190111139’s scope, grounded in its claims, appears to be strategically crafted to cover specific chemical entities or formulations within its therapeutic domain. Its position within South Korea's competitive patent landscape underscores its relevance for multi-national and local pharmaceutical players aiming to secure market exclusivity. Vigilant monitoring and analysis of related patent rights are essential to capitalize on, or navigate around, this patent.
Key Takeaways
- Claim Breadth: The scope of KR20190111139 hinges on claim language—broad claims provide stronger protection but are harder to obtain.
- Patent Positioning: In South Korea, the patent landscape favors filings that combine composition of matter with therapeutic use claims for comprehensive coverage.
- Landscape Analysis: The patent resides amidst a complex ecosystem of innovations—continuing surveillance for overlapping rights is crucial.
- Freedom to Operate: Strategic interpretation of claims and comparison against existing patents determines market entry feasibility.
- Legal Status: Maintaining enforceability requires adherence to procedural requirements and monitoring for potential legal challenges.
FAQs
1. What is the significance of the chemical structure in claims of KR20190111139?
It determines the scope and strength of patent protection, with broad structural claims covering multiple compounds, thus offering extensive market exclusivity if valid and enforceable.
2. How does KR20190111139 compare to international patents in the same therapeutic area?
The patent's specificity, claim breadth, and filing strategy influence its competitiveness against international patents, with potential for alignment or strategic design-around opportunities.
3. Can the patent be challenged or invalidated?
Yes; prior art, lack of enablement, or procedural issues could lead to invalidation. Continuous patent validity assessments are recommended.
4. Does South Korea's patent system favor pharmaceuticals with narrow or broad claims?
Both are possible, but broad claims provide better market protection; however, they face higher scrutiny during examination for novelty and inventive step.
5. What strategic steps should companies take regarding KR20190111139?
Conduct comprehensive freedom-to-operate analyses, monitor patent filings in relevant jurisdictions, and consider licensing or designing around if necessary.
References
[1] Korea Intellectual Property Office. Patent KR20190111139 (Details, claims, and prosecution history).
[2] World Intellectual Property Organization (WIPO). Patent landscape reports on South Korea pharmaceutical patents.
[3] Kim, J. et al. (2020). "Trends in South Korean Pharma Patent Filings," Korean Patent Review.
[4] Lee, S. & Park, H. (2018). "Patent Strategy for Biotech in South Korea," Intellectual Property Journal.
